The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

December 1988

Volume 28, Issue 12

Pages 1059–1140

  1. Pharmacokinetics

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Renal Disease
    5. Cardiovascular Drugs
    6. CNS Pharmacology
    7. Pharmacokinetics
    1. Population Pharmacokinetics (pages 1059–1063)

      T. M. Ludden

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05714.x

  2. Regulatory Affairs

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Renal Disease
    5. Cardiovascular Drugs
    6. CNS Pharmacology
    7. Pharmacokinetics
    1. Worldwide Variation in Chloramphenicol Utilization: Should It Cause Concern? (pages 1071–1075)

      Dr. C. R. Kumana, K. Y. Li and P. Y. Chau

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05716.x

  3. Renal Disease

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Renal Disease
    5. Cardiovascular Drugs
    6. CNS Pharmacology
    7. Pharmacokinetics
    1. The Effects of Renal Function on the Disposition of Isradipine (pages 1076–1080)

      Mary H. H. Chandler, Horst F. Schran, Ralph E. Cutler, Albert J. Smith, Leonard M. Gonasun and Robert A. Blouin

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05717.x

    2. Ranitidine Accumulation in Patients Undergoing Chronic Hemodialysis (pages 1081–1085)

      Drs. Thomas J. Comstock, Dr. Domenic A. Sica, Susan Stone, Ms. Judy Davis, William R. Garnett, H. Thomas Karnes and Dr. Christopher W. Warner

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05718.x

    3. Recombinant Human Erythropoietin Therapy in End Stage Renal Failure (pages 1086–1088)

      Alan J. Watson and Jerry L. Spivak

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05719.x

  4. Cardiovascular Drugs

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Renal Disease
    5. Cardiovascular Drugs
    6. CNS Pharmacology
    7. Pharmacokinetics
    1. Enhanced Pirmenol Elimination by Rifampin (pages 1094–1097)

      Kathleen A. Stringer, Anne B. Cetnarowski, Allen Goldfarb, M. E. Lebsack, Tsun Chang and Allen J. Sedman

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05721.x

    2. The Hemodynamic Effects of Intravenous Ranitidine in Intensive Care Unit Patients: A Double-Blind Prospective Study (pages 1098–1100)

      David Onofrey, Kathleen M. Kelly, David R. Gentili, Ernest Benjamin and Thomas J. Iberti

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05722.x

    3. Pharmacodynamic Comparison of l-Bunolol with Propranolol, Metoprolol, and Placebo (pages 1101–1105)

      Prof. Hermann R. Ochs, Heinrich Bahrmann, David J. Greenblatt and Lothar Labedzki

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05723.x

  5. CNS Pharmacology

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Renal Disease
    5. Cardiovascular Drugs
    6. CNS Pharmacology
    7. Pharmacokinetics
    1. Suppression of Pentylenetetrazol-Elicited Seizure Activity by Intraosseous Propranolol in Pigs (pages 1106–1111)

      Drs. Kam F. Jim, Dr. Claire M. Lathers, Dr. William H. Spivey, Dr. William D. Matthews, Dr. Clare Kahn and Ms. Kathleen Dolce

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05724.x

    2. Lack of Effect of Cholestyramine on Phenytoin Bioavailability (pages 1112–1114)

      Dr. N. Barzaghi, M. Monteleone, C. Amione, S. Lecchini, E. Perucca and G. M. Frigo

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05725.x

  6. Pharmacokinetics

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Renal Disease
    5. Cardiovascular Drugs
    6. CNS Pharmacology
    7. Pharmacokinetics
    1. Influence of Food on Tianeptine and Its Main Metabolite Kinetics (pages 1115–1119)

      Professor . A. Dresse, J. M. Rosen, H. Brems, H. Masset, R. Defrance and C. Salvadori

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05726.x

    2. Lack of Interaction Between Nizatidine and Warfarin During Chronic Administration (pages 1120–1122)

      Dr. Antoine Cournot, Dr. Ivan Berlin, Dr. Jean Claude Sallord and Dr. Eric Singlas

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05727.x

    3. Interaction of Alcohol and Transdermally Administered Scopolamine (pages 1123–1127)

      Dr. Christoph H. Gleiter, Karl-Heinz Antonin, Wolf Schoenleber and Peter R. Bieck

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05728.x

    4. Absorption of Naproxen Controlled-Release Tablets in Fasting and Postprandial Volunteers (pages 1128–1131)

      Edward Mroszczak, James P. Yee and Lincoln Bynum

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05729.x

    5. Comparative Bioavailability of Suprofen After Coadministration with Food or Milk (pages 1132–1135)

      Philip Chaikin, Thomas B. Marriott, David Simon and Howard S. Weintraub

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05730.x

    6. Comparison of Excretion of Nicotinuric Acid After Ingestion of Two Controlled Release Nicotinic Acid Preparations in Man (pages 1136–1140)

      Helen L. Figge, James Figge, Paul F. Souney, Frank M. Sacks, Leon Shargel, John E. Janosik and Alan F. Kaul

      Version of Record online: 19 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb05731.x

SEARCH

SEARCH BY CITATION